» Articles » PMID: 36834849

Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells Via the Regulation of Multiple Signaling Pathways

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 25
PMID 36834849
Authors
Affiliations
Soon will be listed here.
Abstract

Risk signals are characteristic of many common inflammatory diseases and can function to activate nucleotide-binding oligomerization (NLR) family pyrin domain-containing 3 (NLRP3), the innate immune signal receptor in cytoplasm. The NLRP3 inflammasome plays an important role in the development of liver fibrosis. Activated NLRP3 nucleates the assembly of inflammasomes, leading to the secretion of interleukin (IL)-1β and IL-18, the activation of caspase-1, and the initiation of the inflammatory process. Therefore, it is essential to inhibit the activation of the NLRP3 inflammasome, which plays a vital role in the immune response and in initiating inflammation. RAW 264.7 and LX-2 cells were primed with lipopolysaccharide (LPS) for 4 h and subsequently stimulated for 30 min with 5 mM of adenosine 5'-triphosphate (ATP) to activate the NLRP3 inflammasome. Thymosin beta 4 (Tβ4) was supplemented to RAW264.7 and LX-2 cells 30 min before ATP was added. As a result, we investigated the effects of Tβ4 on the NLRP3 inflammasome. Tβ4 prevented LPS-induced NLRP3 priming by inhibiting NF-kB and JNK/p38 MAPK expression and the LPS and ATP-induced production of reactive oxygen species. Moreover, Tβ4 induced autophagy by controlling autophagy markers (LC3A/B and p62) through the inhibition of the PI3K/AKT/mTOR pathway. LPS combined with ATP significantly increased thee protein expression of inflammatory mediators and NLRP3 inflammasome markers. These events were remarkably suppressed by Tβ4. In conclusion, Tβ4 attenuated NLRP3 inflammasomes by inhibiting NLRP3 inflammasome-related proteins (NLRP3, ASC, IL-1β, and caspase-1). Our results indicate that Tβ4 attenuated the NLRP3 inflammasome through multiple signaling pathway regulations in macrophage and hepatic stellate cells. Therefore, based on the above findings, it is hypothesized that Tβ4 could be a potential inflammatory therapeutic agent targeting the NLRP3 inflammasome in hepatic fibrosis regulation.

Citing Articles

Recent insight into the role of macrophage in alcohol-associated liver disease: a mini-review.

Sun J, Zhao P, Shi Y, Li Y Front Cell Dev Biol. 2023; 11:1292016.

PMID: 38094617 PMC: 10716218. DOI: 10.3389/fcell.2023.1292016.


Role and significance of SIRT1 in regulating the LPS-activated pyroptosis pathway in children with congenital hydronephrosis.

Wang Z, Weizhong G, Zhou J, Tang D World J Pediatr Surg. 2023; 6(4):e000602.

PMID: 37534327 PMC: 10391807. DOI: 10.1136/wjps-2023-000602.


CircUTRN24/miR-483-3p/IGF-1 Regulates Autophagy Mediated Liver Fibrosis in Biliary Atresia.

Liu D, Wu Z, Gao J, Mei Q, Zhang X, Wang B Mol Biotechnol. 2023; 66(6):1424-1433.

PMID: 37369954 DOI: 10.1007/s12033-023-00802-2.


Thymosin Beta 4 Protects Hippocampal Neuronal Cells against PrP (106-126) via Neurotrophic Factor Signaling.

Kim S, Choi J, Kwon J Molecules. 2023; 28(9).

PMID: 37175330 PMC: 10180446. DOI: 10.3390/molecules28093920.

References
1.
Bansal R, van Baarlen J, Storm G, Prakash J . The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. Sci Rep. 2015; 5:18272. PMC: 4677309. DOI: 10.1038/srep18272. View

2.
Kim J, Jung Y . Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci. 2015; 16(5):10624-35. PMC: 4463665. DOI: 10.3390/ijms160510624. View

3.
De Nardo D, De Nardo C, Latz E . New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am J Pathol. 2013; 184(1):42-54. PMC: 3873477. DOI: 10.1016/j.ajpath.2013.09.007. View

4.
Liu X, Zhang X, Ding Y, Zhou W, Tao L, Lu P . Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming. Antioxid Redox Signal. 2016; 26(1):28-43. PMC: 5198158. DOI: 10.1089/ars.2015.6615. View

5.
Han H, Kim S, Kwon J . Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells. Neurotox Res. 2018; 36(1):58-65. DOI: 10.1007/s12640-018-9985-0. View